RT Journal Article
SR Electronic
T1 Modelling interventions to control COVID-19 outbreaks in a refugee camp
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.07.20140996
DO 10.1101/2020.07.07.20140996
A1 R. Tucker Gilman
A1 Siyana Mahroof-Shaffi
A1 Christian Harkensee
A1 Andrew T. Chamberlain
YR 2020
UL http://medrxiv.org/content/early/2020/07/07/2020.07.07.20140996.abstract
AB Refugee camp populations are expected to be vulnerable to COVID-19 due to overcrowding, unsanitary conditions, and inadequate medical facilities. Because there has been no COVID-19 outbreak in a refugee camp to date, the potential for nonpharmaceutical interventions to slow the spread of COVID-19 in refugee camps remains untested. We used an agent-based model to simulate COVID-19 outbreaks in the Moria refugee camp, and we studied the effects of feasible interventions. Subdividing the camp (‘sectoring’) “flattened the curve,” reducing peak infection by up to 70% and delaying peak infection by up to several months. The use of face masks coupled with efficient isolation of infected individuals reduced the overall incidence of infection and sometimes averted epidemics altogether. These interventions must be implemented quickly to be effective. Lockdowns had little effect on COVID-19 dynamics. Our findings provide an evidence base for camp managers planning intervention strategies against COVID-19 or future epidemics.Competing Interest StatementRTG reports grants from the European Union's Horizon 2020 research and innovation programme outside of the submitted work. ATC reports grants from NERC and AHRC outside the submitted work. SM-S is the director and CH is a board member (both without financial interest) of the NGO Kitrinos Healthcare (a UK registered charity providing free healthcare inside the Moria camp).Funding StatementThis study was not externally funded. RTG was partially supported by Engineering and Physical Sciences Research Council grant number EP/M506436 during the course of this study, but the funder took no active role in the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Manchester Office of Research Governance, Ethics and IntegrityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOriginal codes for models presented in this study are currently available from the corresponding author. Upon publication of the study, codes and data will be made freely available through the Open Science Foundation (https://osf.io/).